Approval · Notice of Compliance 3808 · 1997
LYDERM: Notice of Compliance 3808
Issued December 8, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3808
- Date
- December 8, 1997
- Company
- Taro Pharmaceuticals IncBrampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- New dosage forms - ointment and gel
- Therapeutic class
- Topical corticosteroid
- Canadian reference product
- LIDEX OINTMENT, TOPSYN GEL
Products in this notice
Medicinal ingredients
- FLUOCINONIDE 0.5 MG per G